This is a preview of subscription content, log in via an institution to check access.
Notes
see Reactions 1677 p6; 803281801 and see Reactions 1475 p3; 803094606 and see Reactions 1458 p4; 803089210
Reference
European Medicines Agency. PRAC recommends suspending hydroxyethyl-starch solutions for infusion from the market. Internet Document : [2 pages], 12 Jan 2018. Available from: URL: http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Hydroxyethyl_starch_107i/Recommendation_provided_by_Pharmacovigilance_Risk_Assessment_Committee/WC500241325.pdf
Rights and permissions
About this article
Cite this article
EU suspension of HES solutions recommended. Reactions Weekly 1686, 4 (2018). https://doi.org/10.1007/s40278-018-41068-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-41068-7